These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7394774)

  • 21. Butylated hydroxytoluene exposure is necessary to induce lung tumors in BALB mice treated with 3-methylcholanthrene.
    Malkinson AM; Koski KM; Evans WA; Festing MF
    Cancer Res; 1997 Jul; 57(14):2832-4. PubMed ID: 9230183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of administration of metabolic inducers and inhibitors on pulmonary toxicity and covalent binding by 1,1-dichloroethylene in CD-1 mice.
    Forkert PG; Stringer V; Racz WJ
    Exp Mol Pathol; 1986 Aug; 45(1):44-58. PubMed ID: 3758307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism of bromobenzene to glutathione adducts in lung slices from mice treated with pneumotoxicants.
    Fakjian N; Buckpitt AR
    Biochem Pharmacol; 1984 May; 33(9):1479-86. PubMed ID: 6732865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of butylated hydroxytoluene-induced lung damage in mice by cedar terpene administration.
    Malkinson AM
    Toxicol Appl Pharmacol; 1979 Jul; 49(3):551-60. PubMed ID: 473220
    [No Abstract]   [Full Text] [Related]  

  • 25. Potentiation of butylated-hydroxytoluene-induced acute lung damage by oxygen. Effects of prednisolone and indomethacin.
    Hakkinen PJ; Schmoyer RL; Witschi HP
    Am Rev Respir Dis; 1983 Oct; 128(4):648-51. PubMed ID: 6625343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decrease in the protein kinase C-catalyzed phosphorylation of an endogenous lung protein (Mr 36,000) following treatment of mice with the tumor-modulatory agent butylated hydroxytoluene.
    Malkinson AM; Beer DS; Sadler AJ; Coffman DS
    Cancer Res; 1985 Nov; 45(11 Pt 2):5751-6. PubMed ID: 4053047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of the incidence of urethane induced mouse lung adenomas by butylated hydroxytoluene (BHT).
    Malkinson AM
    Proc West Pharmacol Soc; 1983; 26():417-9. PubMed ID: 6889373
    [No Abstract]   [Full Text] [Related]  

  • 28. Cell kinetics in mouse lung following administration of carcinogens and butylated hydroxytoluene.
    Witschi HP; Morse CC
    Toxicol Appl Pharmacol; 1985 May; 78(3):464-72. PubMed ID: 4049395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Esterase inhibition and reactivation in relation to piperonyl butoxide-phosphorothionate interactions.
    Levine BS; Murphy SD
    Toxicol Appl Pharmacol; 1977 Jun; 40(3):379-91. PubMed ID: 882977
    [No Abstract]   [Full Text] [Related]  

  • 30. Carbonyl reductase inactivation may contribute to mouse lung tumor promotion by electrophilic metabolites of butylated hydroxytoluene: protein alkylation in vivo and in vitro.
    Shearn CT; Fritz KS; Meier BW; Kirichenko OV; Thompson JA
    Chem Res Toxicol; 2008 Aug; 21(8):1631-41. PubMed ID: 18597497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung damage induced by butylated hydroxytoluene in mice. Biochemical, cellular, and morphologic characterization.
    Smith LJ
    Am Rev Respir Dis; 1984 Nov; 130(5):895-904. PubMed ID: 6093659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced acute lung damage in mice following administration of 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Kehrer JP; Klein-Szanto AJ
    Cancer Res; 1985 Nov; 45(11 Pt 2):5707-13. PubMed ID: 4053044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic activation of butylated hydroxytoluene by mouse bronchiolar Clara cells.
    Bolton JL; Thompson JA; Allentoff AJ; Miley FB; Malkinson AM
    Toxicol Appl Pharmacol; 1993 Nov; 123(1):43-9. PubMed ID: 8236260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of butylated hydroxytoluene-induced mouse lung damage by butylated hydroxyanisole.
    Thompson DC; Trush MA
    Toxicol Appl Pharmacol; 1988 Oct; 96(1):115-21. PubMed ID: 3188016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation of acute chloroform nephrotoxicity by the glutathione depletor diethyl maleate and protection by the microsomal enzyme inhibitor piperonyl butoxide.
    Kluwe WM; Hook JB
    Toxicol Appl Pharmacol; 1981 Jul; 59(3):457-66. PubMed ID: 7268770
    [No Abstract]   [Full Text] [Related]  

  • 36. Butylated hydroxytoluene (BHT).
    IARC Monogr Eval Carcinog Risk Chem Hum; 1986; 40():161-206. PubMed ID: 3473001
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention of butylated hydroxytoluene-induced lung damage by diethyldithiocarbamate and carbon disulfide in mice.
    Masuda Y; Nakayama N
    Toxicol Appl Pharmacol; 1984 Aug; 75(1):81-90. PubMed ID: 6087497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary toxicity of butylated hydroxytoluene and related alkylphenols: structural requirements for toxic potency in mice.
    Mizutani T; Ishida I; Yamamoto K; Tajima K
    Toxicol Appl Pharmacol; 1982 Feb; 62(2):273-81. PubMed ID: 7058530
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of dietary butylated hydroxytoluene and phenobarbital on the activities of ornithine decarboxylase and thymidine kinase in rat liver and lung.
    Saccone GT; Pariza MW
    Cancer Lett; 1978 Sep; 5(3):145-52. PubMed ID: 688194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of inducers and inhibitors of cytochrome P-450-linked monooxygenases on the toxicity, in vitro metabolism and in vivo irreversible binding of 2-methylnaphthalene in mice.
    Griffin KA; Johnson CB; Breger RK; Franklin RB
    J Pharmacol Exp Ther; 1982 Jun; 221(3):517-24. PubMed ID: 7086669
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.